Therapeutic Effect of Ticlopidine, a New Inhibitor of Platelet Aggregation, on Chronic Arterial Occlusive Diseases, a Double-blind Study versus Placebo

Katsumura, Tatsuki; Mishima, Yoshio; Kamiya, Kisaku; Sakaguchi, Shukichi; Tanabe, Tatsuzo; Sakuma, Akira
June 1982
Angiology;Jun1982, Vol. 33 Issue 6, p357
Academic Journal
The clinical efficacy of ticlopidine, a platelet aggregation inhibitor, was evaluated in a double-blind placebo-controlled study on 193 patients with ischemic ulcers due to chronic arterial occlusion. In the group treated with ticlopidine, significantly better efficacy was noted over the placebo group in terms of judgment on overall improvement by doctors in charge as well as by the committee assessing with color slide films. The drug was particularly effective for the treatment of patients with occlusion in the arteries on the distal side and for the ischemic ulcer with relatively small size. In the group with ticlopidine, granulation was significantly improved compared to the placebo group. Those patients who had pain due to arterial occlusion on the distal side were significantly improved by this agent. The mean diameters of ulcers were clearly reduced. Therefore, this agent could possibly be claimed as an effective remedy against the main symptoms of chronic arterial occlusion. The frequencies of side effects and abnormalities in laboratory tests were comparable in the group treated with ticlopidine to those of the group with placebo. It was, therefore, concluded that this agent has an outstanding clinical value as a conservative treatment in chronic arterial occlusion.


Related Articles

  • RECENT ADVANCES IN SURGERY FOR OBLITERATIVE ARTERIAL DISEASE. Pratt, Gerald H. // Angiology;Dec1951, Vol. 2 Issue 6, p517 

    1) The importance of obliterative arterial disease is discussed. 2) Simple measures to combat the occlusive arterial diseases have been advocated. 3) Anticoagulant therapy for this group and frost bite patients is advised, and surgeons are urged to familiarize themselves with the use and control...

  • Three-Month Therapy with Calcium-Heparin in Comparison with Ticlopidine in Patients with Peripheral Arterial Occlusive Disease at Leriche-Fontaine IIb Class. Andreozzi, Giuseppe Maria; Signorelli, Salvatore Santo; Cacciaguerra, Giuseppe; Di Pino, Luigi; Martini, Romeo; Monaco, Sergio; Butto', Giuseppe; Sardina, Marco // Angiology;Apr1993, Vol. 44 Issue 4, p307 

    Forty patients with a mean age of 62.6 ± 6 years, 36 men and 4 women, with peripheral arterial occlusive disease (PAOD) at Leriche-Fontaine lib class, were randomly allocated to one of two treatment groups, receiving either 12,500 IU/day of subcutaneous (sc) calcium-heparin (CAE) or 250...

  • A NEW APPROACH IN THE TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIONS: DEFIBRINATION WITH ARVIN. Ehringer, Herbert; Dudczak, R.; Lechner, K. // Angiology;Apr1974, Vol. 25 Issue 4, p279 

    Therapeutical defibrination induced by a 10 day's arvin infusion period caused a more pronounced and more sustained decrease of blood viscosity as compared with SK. Simultaneously an increase of the rest flow of the calf and of the foot and an improvement of the efficiency of the collateral...

  • Buflomedil in Arterial Occlusive Disease: Results of a Controlled Multicenter Study. Trubestein, G.; Balzer, K.; Bisler, H.; Kluken, N.; Muller-Wiefel, H.; Unkel, B.; Mahfoud, Y.; Ziegler, W. // Angiology;Aug1984, Vol. 35 Issue 8, p500 

    In a double-blind, randomised multicentre study buflomedii, a vasoactive substance, was compared with placebo in the treatment of 93 patients with chronic arterial occlusive disease. After a run-in period of four weeks the patients received either buflomedil (600 mg daily) or placebo over 12...

  • Long-Term Effects of Ticlopidine on Lower Limb Blood Flow, Ankle/Brachial Index and Symptoms in Peripheral Arteriosclerosis. Fagher, Birger // Angiology;Sep1994, Vol. 45 Issue 9, p777 

    The aim was to test within a randomized double-blind trial whether the platelet inhibitor ticlopidine might improve peripheral blood flow and distal pressures in patients with aortofemoral arteriosclerosis. One hundred and one patients with intermittent claudication were studied after one year,...

  • Is There a Role for Oral Anticoagulant Therapy in Patients with Peripheral Arterial Disease? Cosmi, B.; Palareti, G. // Current Drug Targets - Cardiovascular & Haematological Disorders;Sep2004, Vol. 4 Issue 3, p269 

    Peripheral arterial disease (PAD) is an index of systemic atherosclerotic disease and is associated with a high incidence of atherothrombotic complications in coronary, cerebral and peripheral arteries. While antiplatelet agents have been extensively evaluated and shown to be effective in...

  • Massive pontine hemorrhagic transformation associated with an anticoagulant for basilar artery occlusion. Ming-Chang Hsiao; Jiann-Der Lee; Meng Lee; Hsu-Huei Weng // Neurology India;Dec2006, Vol. 54 Issue 4, p431 

    The article discusses the case of a 66-year-old male patient who developed massive pontine hemorrhagic transformation following anticoagulant for basilar artery occlusion (BAO). Computed tomography images of the patient's brain showed infarction over bilateral thalami and occipital lobes....

  • Naftidrofuryl in Chronic Arterial Disease. Results of a Controlled Multicenter Study. Trubestein, G.; .Bohme, H; Heidrich, H.; Heinrich, F.; Hirche, H.; Maass, U.; Mori, H.; Rudofsky, G. // Angiology;Nov1984, Vol. 35 Issue 11, p701 

    In a double blind, randomized multicenter study naftidrofuryl, a vasoactive substance, was compared with placebo in the treatment of 104 patients with chronic arterial occlusive disease. After a run-in period of four weeks the patients received either naftidrofuryl (600mg daily) or placebo over...

  • Effects of Ticlopidine on the Neurologic Outcome and the Hemorheologic Pattern in the Postacute Phase of Ischemic Stroke: A Pilot Study. Ciuffetti, Giovanni; Aisa, Giovanni; Mercuri, Michele; Lombardini, Rita; Paltriccia, Rita; Neri, Cristiana; Senin, Umberto // Angiology;Jul1990, Vol. 41 Issue 7, p505 

    This double-blind pilot study observed the effects of a twenty-one day oral ticlopidine treatment (250 mg/twice daily) on the neurologic outcome and the hemorheologic pattern of 15 patients and 15 placebo-treated controls. Patients and controls (age range sixty-six to eighty-six years) were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics